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Probing pigmentation and cancer risk
Following previous work that identified an association 
between melanocortin-1 receptor (MCIR) variants and 
pigmentation and skin cancer, Sulem and colleagues per-
formed a genome-wide study of more than 8,000 Icelandic 
and Dutch individuals to discover novel variants associ-
ated with human hair color, eye color, and skin pigmenta-
tion traits such as sun sensitivity, freckling, and burning. A 
two–single-nucleotide polymorphism (SNP) haplotype in a 
region including the ASIP gene, which encodes the agouti 
signaling protein that is known to function in pigmentation, 
was strongly associated with red hair color, freckling, sun 
sensitivity, and burning. In addition, a genome-wide sig-
nificant association between SNPs and a genomic region 
containing TPCN2, which encodes the calcium transport 
protein two-pore segment channel 2, was identified in 
the Icelandic population. This report augments the list of 
sequence variants that are involved in normal pigmenta-
tion in European populations.
In another report by this group, pigmentation variants 
identified in European populations were associated with 
both cutaneous melanoma, a rare aggressive malignant 
melanocyte tumor, and basal cell carcinoma, a common skin 
neoplasm that is unlikely to metastasize. Specifically, vari-
ants of ASIP, TYR, which encodes tyrosinase, and TYRP1, 
which encodes tyrosinase-related protein 1, were significant-
ly associated with cutaneous melanoma, whereas variants 
of ASIP and TYR were also associated with basal cell carci-
noma. Although other pigmentation trait–associated variants 
have been identified in these populations, none of the other 
examined loci (SLC242A, KITLG, 6p25.3, OCA2, or TPCN2) 
was associated with these skin neoplasms. These results 
indicate that pigmentation variants may offer insight into 
predisposition to skin cancer in certain populations, and that 
studies of the identified variants are warranted. (Nat Genet, 
published online 18 May 2008; doi:10.1038/ng.160; Nat 
Genet, published online 18 May 2008; doi:10.1038/ng.161)
Mitochondria drive metastasis
Despite the lack of maternal inheritance of tumor develop-
ment, chemical carcinogen-induced somatic mitochondrial 
DNA (mtDNA) mutations, which occur at high frequen-
cies in human tumors, may play a causative role in onco-
genic development or metastasis. Ishikawa and colleagues 
reciprocally exchanged the mtDNA of a highly metastatic 
cell line and a poorly metastatic cell line via cell fusion to 
generate transmitochondrial cybrids. Interestingly, both 
defects in complex I (reduced form of nicotinamide adenine 
dinucleotide (NADH) dehydrogenase) and metastatic ability 
correlated with the cell line of mtDNA origin. Furthermore, 
mutations in the NADH dehydrogenase gene were identified 
in the mtDNA of the highly metastatic cells, and these muta-
tions were correlated with enhanced reactive oxygen spe-
cies (ROS) production, consistent with a complex I defect. 
More importantly, these findings held true in human cancer 
cells as well. MtDNA plays a central role in driving metasta-
sis; thus, treatment with ROS scavengers may offer an effec-
tive therapeutic strategy for suppressing metastasis in human 
cancer patients. (Science 320:661–4, 2008)
Epidermal oxygen sensor
A recent proposal that the human epidermis utilizes oxy-
gen straight from the air, in a manner similar to that of 
amphibians, prompted Boutin and colleagues to exam-
ine the oxygen-sensing properties of keratinocytes under 
hypoxic conditions. In a murine model, the epidermis 
coordinated a systemic hypoxic response and modulated 
cutaneous blood flow via hypoxia-inducible transcription 
factor-1. Deletion of this factor led to decreased erythro-
poietin (EPO) levels in the blood and kidneys. EPO and its 
receptors are critical factors in adaptation to hypoxia and 
may be the primary response to low oxygen concentrations. 
Furthermore, dermal administration of nitric oxide, which 
modulates cutaneous vasodilation in response to hypoxia, 
resulted in increased EPO levels. These data support a role 
for the human epidermis in sensing oxygen levels in the 
atmosphere and translating these findings to a systemic 
response. (Cell 133:223–34, 2008)
Deciphering acne treatment
The most effective drug for the treatment of the most preva-
lent skin condition, acne, is 13-cis retinoic acid (13-cis RA, 
or isotretinoin). However, the molecular mechanisms gov-
erning the success of this treatment are largely unknown, 
due, in part, to the lack of an animal model for this con-
dition. Nelson and colleagues examined skin biopsies 
from seven patients with acne before and after a 1-week 
course of 13-cis RA treatment. Transcriptional profiling 
revealed a dramatic upregulation in the lipocalin-2 gene 
(LCN2), which encodes neutrophil gelatinase–associated 
lipocalin (NGAL). NGAL, an interleukin-17 target gene, 
has been implicated in apoptosis of murine B lymphocytes, 
and, indeed, increased apoptosis was noted in skin-biopsy 
sebocytes following 13-cis RA treatment and in cultured 
sebocytes following recombinant NGAL administration. 
Therefore, 13-cis RA upregulates NGAL, which, in turn, 
mediates therapeutic apoptosis in the sebaceous glands. 
Because 13-cis RA is a serious teratogen, identifying alter-
native, nonteratogenic strategies to modulate NGAL activ-
ity is important and may be useful in treating not only acne 
but other retinoid-responsive conditions such as rosacea, 
psoriasis, neuroblastoma, and promyelocytic leukemia. 
(J Clin Invest 118:1468–78, 2008)
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